Millions of Americans go about their daily routines entirely unaware of a silent, progressive condition affecting their bodies. According to a landmark study by researchers from the Johns Hopkins Bloomberg School of Public Health, an astonishing eleven percent of the U.S. adult population experiences varying chronic kidney disease stages.
This comprehensive research, published in the American Journal of Kidney Diseases, highlights a critical gap in public health awareness. The researchers concluded that chronic kidney disease (CKD) requires vastly improved detection and classification using standardized criteria to ensure patients receive the care they need before irreversible damage occurs.
Understanding how the kidneys function, recognizing the severity of different chronic kidney disease stages, and utilizing simple diagnostic tools are the most effective ways to combat this widespread health issue.
The Vital Role of Your Kidneys
Before diving into the specific chronic kidney disease stages, it is essential to understand what healthy kidneys do. Your kidneys are your body’s ultimate filtration system.
In a healthy young adult of an average body size, the kidneys filter approximately 130 milliliters per minute (ml/min), which translates to an incredible 2 gallons of fluid every single hour. This high-efficiency filtration process is responsible for:
- Removing toxins: Filtering out waste products from the blood to be excreted as urine.
- Secreting hormones: Producing vital hormones that regulate blood pressure, maintain bone health, and stimulate the production of healthy red blood cells.
When kidney function declines, the body becomes less efficient at performing these critical life-sustaining tasks. The presence of chronic kidney disease means this filtration rate has dropped, or there is physical damage to the kidneys allowing vital proteins to leak into the urine.
Breaking Down the Chronic Kidney Disease Stages
To properly diagnose and treat patients, the medical community relies on the National Kidney Foundation Clinical Practice Guidelines. These guidelines provide a standardized definition of CKD, categorized into five distinct chronic kidney disease stages.
The stages are primarily based on the Glomerular Filtration Rate (GFR)—a measure of how well the kidneys are filtering blood—and the presence of protein (albumin) in the urine.
Researchers applied these guidelines to a nationally representative sample of 15,625 non-institutionalized adults via the Third National Health and Nutrition Examination Survey (NHANES III). The findings provided a stark look at how many Americans fall into each category.
| Stage | Clinical Description | GFR Level (ml/min/1.73m2) | Estimated U.S. Adults Affected | Percentage of Population |
| Stage 1 | Normal kidney function with protein in urine | Normal (≥ 90) | 5.9 million | 3.3% |
| Stage 2 | Mildly decreased function with protein in urine | Mild Decrease (60–89) | 5.3 million | 3.0% |
| Stage 3 | Moderately decreased kidney function | 30–59 | 7.6 million | 4.3% |
| Stage 4 | Severely decreased kidney function | 15–29 | 400,000 | 0.2% |
| Stage 5 | Kidney failure (End-Stage Renal Disease) | < 15 (or dialysis) | 300,000 | 0.2% |
The Alarming Reality of Stage 3
When examining the progression of chronic kidney disease stages, Stage 3 stands out as a significant public health concern. Of the five categorical stages, the largest number of affected adults—7.6 million, or 4 percent of the adult population—are classified in Stage 3.
At this stage, a patient’s GFR is between 30 and 59 ml/min/1.73m2. In practical terms, this means their kidneys are filtering less than one-half of the amount filtered by a healthy young adult.
Because the kidneys are operating at less than 50% capacity, they struggle to efficiently remove toxins and secrete the hormones necessary for optimal health. Patients in Stage 3 often suffer from secondary treatable conditions that arise from this systemic stress, including:
- Hypertension (High Blood Pressure): The kidneys lose their ability to effectively regulate blood volume and vessel constriction.
- Anemia: A lack of the hormone erythropoietin leads to a reduced red blood cell count.
- Poor Nutritional Status: Toxin buildup can affect appetite and the body’s ability to absorb nutrients.
More alarmingly, patients with moderate chronic kidney disease are at a highly elevated risk for severe cardiovascular events, such as heart attacks and strokes.
Demographics and the Aging Population
The prevalence of reduced kidney function is not distributed evenly across the population. Dr. Josef Coresh, MD, PhD, lead author of the study and an associate professor of epidemiology, medicine, and biostatistics at the Johns Hopkins Bloomberg School of Public Health, noted the profound impact of age on the disease.
“As the population ages, kidney disease will become more apparent. However, there is already a growing recognition of the importance of moderate and severe chronic kidney disease, prior to the onset of kidney failure requiring dialysis, as an important treatable condition.” — Dr. Josef Coresh
The study estimates that a staggering one out of every five Americans over the age of 65 has less than half the normal kidney function of a young adult.
Beyond age, the study revealed fascinating, and somewhat paradoxical, racial and ethnic disparities:
- Highest Prevalence of Reduced Function: Moderately decreased kidney function was found to be most prevalent among non-Hispanic whites.
- Middle Prevalence: Non-Hispanic blacks followed closely behind in the prevalence of moderate function decrease, followed by individuals of other ethnicities.
- Lowest Prevalence: Kidney disease was found to be least prevalent in Mexican Americans.
However, researchers noted a critical caveat. Despite minority populations having a lower overall prevalence of milder kidney disease, they historically face a higher risk of total kidney failure. These results raise the distinct possibility that minority populations experience a much more rapid progression of the disease after its onset.
The Gap in Diagnosis and Treatment
One of the most pressing issues surrounding these chronic kidney disease stages is the sheer volume of undiagnosed cases. The study’s estimates of decreased kidney function dramatically exceed the number of patients actively treated for end-stage renal disease (Stage 5).
To put this into perspective, in 1999, just over 340,000 patients required life-sustaining dialysis or kidney transplantation. That number was projected to nearly double to 651,000 by 2010. Yet, sitting just below the surface of those catastrophic kidney failure numbers are approximately 8 million people with moderate to severe dysfunction, and another 11 million adults who have a persistent presence of albumin (the main protein in blood) leaking into their urine.
Previous reviews of patients’ medical charts have consistently indicated that individuals are going undiagnosed and under-treated in the crucial early stages of the disease.
How is CKD detected?
The tragedy of undiagnosed kidney disease is that detection is remarkably straightforward. It does not require invasive procedures. The presence of kidney disease can be confirmed using simple, accessible tests:
- Blood Tests: Relying on serum creatinine levels to estimate kidney function and calculate the patient’s GFR.
- Urine Tests: Checking for urinary albumin to indicate physical kidney damage and protein leakage.
Setting a Benchmark for the Future
Familiarizing both medical professionals and patients with standardized criteria is the ultimate key to shifting the tide.
Dr. Coresh, who also serves as a faculty member in the Johns Hopkins Welch Center for Prevention, Epidemiology & Clinical Research, emphasized the importance of this data: “By using standardized criteria and carefully calibrated estimates of kidney function, national prevalence estimates of chronic kidney disease can be a benchmark for future studies and international comparisons. Such efforts are critical to improving diagnosis, treatment, and prevention of CKD and its complications.”
By actively screening for early-stage markers—especially in individuals over 65 or those with a history of diabetes and hypertension—healthcare providers can intervene before the disease rapidly progresses. Addressing treatable conditions like high blood pressure and anemia early on can protect remaining kidney function and drastically reduce the risk of fatal cardiovascular events.
Early intervention relies entirely on awareness. If you or a loved one are in a high-risk category, advocating for a simple blood and urine test could be a life-saving decision.
